Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19394894 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Study Of Lapatinib In Patients With Relapsed Or Refractory Inflammatory Breast Cancer
Condition: Neoplasms, Breast
Intervention: Drug: lapatinib

Indicates status has not been verified in more than two years